Predicting 28-Day Survival in OHCA Patients
Key facts
- Who runs it
- Haseki Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 327 people enrolled
- Started
- 1 May 2023
- Ended
- 1 Jun 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Demographics
- Comorbidities
- Prehospital Variables
- Hematological Parameters
- Biochemical Parameters
- Arterial Blood Gas Parameters
- Record updated
- 15 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- This study included 420 adult patients (aged ≥18 years) who were brought to our hospital's ED due to OHCA and who had initiated attempted resuscitation by EMS were initially screened for inclusion between May 2023 and May 2024
Who cannot take part
- Patients with in-hospital cardiac arrest
- Patients who have suffered cardiac arrest due to major trauma, drowning, drug overdose, or known terminal illness
- Patients with active hematologic malignancy
- Patients with incomplete data regarding primary outcomes or admission laboratory tests
- Patients aged < 18 years
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective study aimed to identify clinical and laboratory predictors of return of spontaneous circulation (ROSC), 28-day survival, and favorable neurological outcomes in adult patients experiencing out-of-hospital cardiac arrest (OHCA) and brought to the emergency department (ED) by emergency medical services (EMS). Specifically, the prognostic value of hematologic, biochemical, and blood gas parameters on admission was assessed for ROSC, 28-day survival, and favorable neurological recovery. Additionally, the study investigated the influence of key patient-centered and prehospital variables, including demographic features, initial cardiac rhythm, and the timeliness and type of cardiopulmonary resuscitation (CPR), defibrillation, and airway interventions, on overall survival and neurological status.
The 2 groups in the trial
- Survivors
Survivors were defined as the patient being alive at 28 days following the cardiac arrest event.
Treatment: Demographics, Comorbidities, Prehospital Variables, Hematological Parameters, Biochemical Parameters, and Arterial Blood Gas Parameters
- Non-survivors
Non-survivors had passed away within 28 days following the cardiac arrest event.
Treatment: Demographics, Comorbidities, Prehospital Variables, Hematological Parameters, Biochemical Parameters, and Arterial Blood Gas Parameters
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Predicting Clinical Factors and Laboratory Parameters Associated With Short-Term Survival in Out-of-Hospital Cardiac Arrest
- Record updated
- 15 June 2025